Louise Rodino-Klapac

Chief Scientific Officer & Head of R&D

Louise Rodino-Klapac, Ph.D. has served as Chief Scientific Officer & Head of R&D since 2021.

Renowned for her work in molecular genetics and gene therapy, Dr. Rodino-Klapac was head of the laboratory for gene therapy research for muscular dystrophies at Nationwide Children’s Hospital prior to joining Sarepta.

From July 2010 to June 2018, Dr. ...

Roles at Sarepta Therapeutics

  • Chief Scientific Officer & Head of R&D

    2021 - present

  • EVP, Chief Scientific Officer

    December, 2020

  • SVP, Gene Therapy

Org chart

Direct reports

No reports


No teams

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.